<DOC>
	<DOCNO>NCT01893411</DOCNO>
	<brief_summary>The purpose study determine whether injection Botulinum toxin type A muscle leg ( ) effective treat children/adolescents ( age 2-17 year ) increase muscle tension/uncontrollable muscle stiffness ( spasticity ) due cerebral palsy .</brief_summary>
	<brief_title>Dose-response Study Efficacy Safety Botulinum Toxin Type A Treat Spasticity Leg ( ) Cerebral Palsy</brief_title>
	<detailed_description />
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Female male subject 2 17 year age ( inclusive ) . Uni bilateral cerebral palsy clinical need uni bilateral LL injection BoNT treatment spasticity . Ashworth Scale [ AS ] score â‰¥2 plantar flexor ( least unilaterally ) . Clinical need total dose 16 U/kg BW NT 201 ( maximum 400 U ) treatment LL spasticity accord clinical judgment investigator . Fixed contracture define severe restriction range joint movement passive stretch predominant form muscle hypertonia spasticity ( e.g. , dystonia ) target limb ( ) . Surgery pes equinus side ( ) intend treat BoNT injection study within 12 month prior Screening Visit ( V1 ) , screen period plan time participation study . Hip flexion require BoNT injection .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>